Acute Graft Versus Host Disease in Intestine research hub

Early Access Program With MaaT013 in Steroid-refractory Acute Gastrointestinal Graft Versus Host Disease

This early access program is for people with a serious gut condition called acute Graft-versus-Host Disease (aGvHD) that hasn’t responded to standard medicine (steroids). It's using an unapproved treatment called MaaT013 to see if it can help patients who have run out of other options.